Insmed Shares Rise Following Reports of Potential Acquisition Interest from Sanofi
Shares of Insmed (INSM) surged 6.9% following reports that pharmaceutical giant Sanofi (SNY) is evaluating a potential acquisition of the drugmaker. According to reports, Sanofi has engaged advisers to explore the possibility of a deal. The market reacted divergently to the news; while Insmed's stock price climbed on takeover speculation, Sanofi ADRs saw a decline of 3%. The move highlights ongoing consolidation trends within the biotechnology and pharmaceutical sectors as larger firms seek to bolster their drug pipelines.

Topics: Biotechnology M&A Pharmaceuticals
Read the full article at Seeking Alpha
Part of the story Rhythm Pharmaceuticals Shares Rise Following Reports of Potential Eli Lilly Acquisition Interest (3 articles)